Patent · US Active

Heterodimeric antibodies that bind ENPP3 and CD3

US11472890B2 · kind B2 · utility

5Cited by

127References

4Claims

0Family size

Assignee

Xencor, Inc. · US

Inventors

Rumana Rashid · Temple City, US
Umesh Muchhal · Monrovia, US
Gregory Moore · Monrovia, US
Alex Nisthal · Monrovia, US
Seung Chu · Cypress, US
Sung-Hyung Lee · San Gabriel, US
Yoon Kyung Kim · Pomona, US

Key dates

Filing date	Feb 28, 2020
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Aug 9, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/622
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.